Luxury Villas and Homes COVID-19 Policy on Managed Villas

We understand that flexibility is required given the impact Coronavirus has on travel. In the event where your trip is disrupted due to Covid-19, the below terms and conditions apply:

Should you wish to cancel your booking, we will supply you with the necessary paperwork to file a claim with your travel insurance. If you are not covered by travel insurance, please refer to the policies on our managed villas below in the event your trip is disrupted.

For existing booking before 1st of July 2021, the prior cancellation policies apply. If the booking arrival date is more than thirty (30) days, you are given the flexibility to postpone the booking and convert it into credit:

For new bookings from 1st of July 2021 onwards:

We will refund your booking or provide a credit note based on the following conditions:

Terms and Conditions:

Our Partner’s COVID-19 Policy

For villas that are not part of our managed portfolio, please reach out to us at ([email protected]) so we can provide you with the latest cancellation policy for your desired property.

COVID-19 Health & Safety Guidelines

For our exclusively managed villas, we operate to 5-star standards and have adapted our usual practices in line with World Health Organization (WHO) guidelines and best global practices to ensure the villas remain a COVID-safe getaway:

Cleanliness at the villa

Your safety

Social distancing

Staff vaccinations

SHA Certifications

Please Note: Guidelines may vary for a few villas. Please double check with our Reservations team ([email protected]) upon enquiry.

COVID-19 Travel Guidelines & Requirements

Updated as of 23 June 2021

The safety and wellbeing of guests and staff remain the top priority for LVH. In response to the sudden spike in COVID-19 cases in Thailand, we have decided to enforce the following requirements for new arrivals:

We will continue to monitor the COVID-19 situation in Thailand and will make policy adjustments accordingly.

*Guests are considered fully vaccinated for COVID-19 ≥2 weeks after they have received the second dose in a 2-dose series (Pfizer-BioNTech, Moderna, Sinovac, AstraZeneca etc.), or ≥2weeks after they have received a single-dose vaccine (Johnson & Johnson [J&J]/Janssen).